Sargassum muticum (Japanese Wireweed)
Sargassum muticum, or Japanese Wireweed, is a brown alga rich in phlorotannins and fucoxanthin, compounds associated with antioxidant and anti-inflammatory properties. These bioactive molecules contribute to its potential health benefits, currently explored in preliminary research.

Origin & History
Sargassum muticum (Japanese wireweed) is a large brown seaweed native to the Western Pacific Ocean coasts of China, South Korea, Japan, and southern Russia. It contains 26.46% alginate, 53.35% total sugars, and various phenolic compounds, typically extracted through enzymatic hydrolysis using Shewanella oneidensis PKA 1008 crude enzyme or acid-alkali hydrolysis methods.
Historical & Cultural Context
Sargassum muticum is consumed as food in Korea, though no detailed historical context in traditional medicine systems is documented. Modern potential applications include biosorption of heavy metals and use as a flocculant for sewage treatment, leveraging its alginate and fucoidan content.
Health Benefits
• Anti-inflammatory effects demonstrated in enzymatic extracts (in vitro studies only) • Antioxidant activity from phenolic compounds including phlorotannins and catechins (preliminary evidence) • Source of fucoxanthin with potential anti-cancer properties (no human studies available) • Rich in vitamins C, E, and K providing nutritional support (compositional analysis only) • Contains alginate and fucoidan polysaccharides with bioactive potential (no clinical trials conducted)
How It Works
Sargassum muticum's anti-inflammatory effects are attributed to enzymatic extracts, potentially via modulation of inflammatory mediators like COX-2. Its potent antioxidant activity stems from phenolic compounds, including phlorotannins and catechins, which scavenge free radicals. Fucoxanthin, a carotenoid within the alga, may induce apoptosis in cancer cells and inhibit angiogenesis, though human pathways require further elucidation.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses on Sargassum muticum were identified in the available research. Current evidence is limited to in vitro anti-inflammatory effects of enzymatic extracts and compositional analyses showing antioxidant compounds like fucoxanthin and phlorotannins.
Clinical Summary
Current evidence on Sargassum muticum's health benefits is primarily derived from in vitro and animal studies, with a significant lack of human clinical trials. Preliminary enzymatic extract studies demonstrate anti-inflammatory effects in cellular models. Antioxidant activity linked to phlorotannins and catechins has been observed, but these findings have not been replicated or confirmed in human subjects or quantified with specific dosages. The potential anti-cancer properties of fucoxanthin remain speculative without clinical validation.
Nutritional Profile
Macronutrients (per 100 g dry weight): Protein 8–14 g (primarily glycoproteins and lectins; digestibility and bioavailability in humans not formally established); Total lipids 1–3 g (dominated by polyunsaturated fatty acids, notably eicosapentaenoic acid (EPA, C20:5 n-3) at ~0.2–0.5 g/100 g dw and smaller amounts of arachidonic acid (C20:4 n-6)); Total dietary fiber 40–55 g, of which soluble fiber (alginate ~15–22 g, fucoidan ~3–6 g, laminarin ~2–4 g) and insoluble fiber (cellulose ~5–8 g); Available carbohydrates (mannitol, other low-MW sugars) ~5–10 g; Ash content 20–35 g reflecting high mineral load. Micronutrients: Iodine 50–200 mg/100 g dw (highly variable with season and geography; bioavailability is high, posing thyroid-related safety concerns at even modest intake); Calcium ~700–1,200 mg; Magnesium ~500–900 mg; Potassium ~2,000–5,000 mg; Iron ~15–50 mg (primarily non-heme, bioavailability estimated <10% without ascorbic acid co-consumption); Sodium ~2,000–4,000 mg; Zinc ~3–7 mg; Manganese ~2–5 mg; Phosphorus ~200–400 mg. Vitamins: Vitamin C (ascorbic acid) ~50–200 mg/100 g dw (degrades significantly with drying and storage); Vitamin E (α-tocopherol) ~2–8 mg; Vitamin K₁ ~10–30 µg (estimated); B-vitamins present in trace amounts (B₁, B₂, B₁₂ analog — note B₁₂ analogs from algae may be biologically inactive pseudovitamin). Bioactive compounds: Phlorotannins (oligomeric/polymeric phloroglucinol derivatives) ~1–5 g/100 g dw — primary contributor to antioxidant capacity; bioavailability in humans is poorly characterized but likely low due to high molecular weight and protein-binding. Fucoxanthin ~0.01–0.1 g/100 g dw (carotenoid xanthophyll; lipophilic, bioavailability enhanced by co-ingestion with dietary fat; converted partially to fucoxanthinol and amarouciaxanthin A in mammals). Catechins and other low-MW phenolics present at lower concentrations (~0.1–0.5 g/100 g dw). Sulfated polysaccharides (fucoidan): exhibit documented in vitro bioactivities; oral bioavailability in humans is uncertain and likely limited due to high molecular weight. Heavy metal accumulation note: Sargassum muticum bioaccumulates arsenic (often >10 mg/kg dw, largely organic arsenosugars but inorganic arsenic fraction must be monitored), cadmium, lead, and other trace metals depending on water quality — safety screening essential before dietary use. Overall bioavailability caveat: Most nutritional and bioactive compound data derive from chemical extraction and in vitro assays; human absorption, metabolism, and efficacy data for S. muticum–specific preparations remain largely absent.
Preparation & Dosage
No clinically studied dosage ranges are available for Sargassum muticum in humans. Laboratory preparations use 20 mg/mL concentrations for enzymatic extraction, but these are not established for human consumption. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Fucus vesiculosus, Laminaria digitata, Chlorella vulgaris, Spirulina platensis, Ascophyllum nodosum
Safety & Interactions
Sargassum muticum, like other sea vegetables, can be high in iodine, posing a risk of thyroid dysfunction for individuals with pre-existing thyroid conditions or high intake. Potential for heavy metal accumulation (e.g., arsenic, cadmium) exists depending on harvesting location, requiring careful sourcing. Due to its potential anticoagulant properties, caution is advised for individuals on blood-thinning medications. Safety during pregnancy and lactation is not established and should be avoided.